Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -44.25% is in line with its 5-year average of -48.61%, near the high end of its 5-year range (-193.06%–1.23%).
18.82% below its 12-month average of -37.24%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2025-12-31): -21.74%.
NET PROFIT MARGIN
-44.25%
NET PROFIT MARGIN AVG TTM
-37.24%
NET PROFIT MARGIN AVG 3Y
-66.31%
NET PROFIT MARGIN AVG 5Y
-48.61%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-18.82%
CURRENT VS 3Y AVG
+33.27%
CURRENT VS 5Y AVG
+8.97%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.06%
median of 853 covered companies
CURRENT VS SECTOR MEDIAN
-73650.00%
vs the sector median at left
Mobile-health Network Solutions Class A Ordinary Shares
Market Cap
$30263.00
Net Profit Margin
-44.25%
TTM Avg
-37.24%
3Y Avg
-66.31%
5Y Avg
-48.61%
Market Cap
$6254.00
Net Profit Margin
N/A
TTM Avg
99.68%
3Y Avg
52.40%
5Y Avg
41.92%
Market Cap
$61580.00
Net Profit Margin
-17690.19%
TTM Avg
-9089.88%
3Y Avg
-5029.73%
5Y Avg
-25219.12%
Market Cap
$70965.00
Net Profit Margin
-22521.52%
TTM Avg
-14229.41%
3Y Avg
-9670.52%
5Y Avg
-6447.01%
Market Cap
$95475.00
Net Profit Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$109567.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$242924.00
Net Profit Margin
-1422.78%
TTM Avg
-951.97%
3Y Avg
-568.57%
5Y Avg
-575.76%
Market Cap
$380715.00
Net Profit Margin
-40439.10%
TTM Avg
-68089.13%
3Y Avg
-51057.85%
5Y Avg
-34126.19%
Market Cap
$381940.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-352.76%
5Y Avg
-376.69%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | $30263.00 | -44.25% | -37.24% | -66.31% | -48.61% |
| NewGenIvf Group Limited (NIVF)vs › | $6254.00 | N/A | 99.68% | 52.40% | 41.92% |
| Akanda Corp. (AKAN)vs › | $61580.00 | -17690.19% | -9089.88% | -5029.73% | -25219.12% |
| PRF Technologies Ltd. (PRFX)vs › | $70965.00 | -22521.52% | -14229.41% | -9670.52% | -6447.01% |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | N/A | 0.00% | 0.00% | 0.00% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109567.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | -1422.78% | -951.97% | -568.57% | -575.76% |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | -40439.10% | -68089.13% | -51057.85% | -34126.19% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | 0.00% | 0.00% | -352.76% | -376.69% |
| XORTX Therapeutics Inc. (XRTX)vs › | $483178.00 | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-46.4%
Net Profit Margin
-44.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-31 | -21.74% |
| 2025-06-30 | -51.26% |
| 2024-12-31 | -38.73% |
| 2024-06-30 | -193.06% |
| 2023-12-31 | -76.84% |
| 2023-06-30 | -39.36% |
| 2022-12-31 | -43.17% |
| 2022-06-30 | 0.81% |
| 2021-12-30 | 1.23% |
| 2021-06-30 | -23.99% |
| 2020-12-30 | -23.99% |
